GB1527133A - Imidazodiazepine derivatives - Google Patents
Imidazodiazepine derivativesInfo
- Publication number
- GB1527133A GB1527133A GB1268978A GB1268978A GB1527133A GB 1527133 A GB1527133 A GB 1527133A GB 1268978 A GB1268978 A GB 1268978A GB 1268978 A GB1268978 A GB 1268978A GB 1527133 A GB1527133 A GB 1527133A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- hydrogen
- substituted
- phenyl
- pyridyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- BMGXAZCDDYTVFV-UHFFFAOYSA-N imidazo[4,5-c]diazepine Chemical class C1=CN=NC2=NC=NC2=C1 BMGXAZCDDYTVFV-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 229910052739 hydrogen Inorganic materials 0.000 abstract 7
- 239000001257 hydrogen Substances 0.000 abstract 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- -1 di-substituted phenyl Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 125000004076 pyridyl group Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 101000653791 Bos taurus Protein S100-A12 Proteins 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 230000001773 anti-convulsant effect Effects 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- KLNFAMGHSZQYHR-UHFFFAOYSA-N imidazo[4,5-i][1,2]benzodiazepine Chemical class C1=CC=NN=C2C3=NC=NC3=CC=C21 KLNFAMGHSZQYHR-UHFFFAOYSA-N 0.000 abstract 1
- 238000007918 intramuscular administration Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
1527133 Substituted imidazobenzodiazepines and their pharmaceutical compositions F HOFFMAXN-LA ROCHE & CO AG 10 Sept 1975 [11 Sept 1974] 12689/78 Divided out of 1527131 Heading C2C The invention comprises compounds of general Formula I wherein R 1 represents hydrogen, C 1-7 alkyl, phenyl, alkoxy-C 1-7 alkyl, substituted phenyl, pyridyl, or aralkyl; R 2 is hydrogen or lower alkyl; R 3 is hydrogen or lower alkyl; R 6 is phenyl, mono- or di-substituted phenyl, pyridyl or mono-substituted pyridyl, but is not nitro-substituted; R 7 is hydroxy, acyl or an aromatic or aliphatic sulphonyl group and the ring Z is selected from systems having the Formulae I(a), (b), (c) and (d) wherein R, represents hydrogen, halogen, CN CF 3 , C 1-7 alkyl, hydroxy-C 1-7 alkyl or C 1-7 alkanoyl; X represents H, Cl, Br or I and T is hydrogen or C 1-7 alkyl and the pharmaceutically acceptable salts thereof. which may be prepared by reaction of the corresponding compound in which R 7 is hydrogen with an acylating or sulphonylating agent or by reducing the corresponding N-oxide with, e.g. borohydride (for details see copending Specification 1,527,131). Pharmaceutical compositions having muscle relaxant, sedative and anti-convulsant activity for intravenous and intramuscular application comprise a compound of Formula I or a pharmaceutically acceptable salt thereof together with a therapeutically compatible carrier or excipient.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50492474A | 1974-09-11 | 1974-09-11 | |
GB37252/75A GB1527131A (en) | 1974-09-11 | 1975-09-10 | Benzo or heterocyclic fused imidazodiazepines and pharmaceutical compositions containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1527133A true GB1527133A (en) | 1978-10-04 |
Family
ID=26263388
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1268978A Expired GB1527133A (en) | 1974-09-11 | 1975-09-10 | Imidazodiazepine derivatives |
GB1269078A Expired GB1527134A (en) | 1974-09-11 | 1975-09-10 | Imidazo derivatives |
GB1268878A Expired GB1527132A (en) | 1974-09-11 | 1975-09-10 | Diazepine derivatives |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1269078A Expired GB1527134A (en) | 1974-09-11 | 1975-09-10 | Imidazo derivatives |
GB1268878A Expired GB1527132A (en) | 1974-09-11 | 1975-09-10 | Diazepine derivatives |
Country Status (1)
Country | Link |
---|---|
GB (3) | GB1527133A (en) |
-
1975
- 1975-09-10 GB GB1268978A patent/GB1527133A/en not_active Expired
- 1975-09-10 GB GB1269078A patent/GB1527134A/en not_active Expired
- 1975-09-10 GB GB1268878A patent/GB1527132A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
GB1527132A (en) | 1978-10-04 |
GB1527134A (en) | 1978-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL108786A0 (en) | 4-aminopyridines, processes for their production and pharmaceutical agents containing them | |
ES8207520A1 (en) | Chloro- and alkoxy-substituted-2,4-diaminoquinazolines and pharmaceutical compositions containing them. | |
FI865037A (en) | MICROBICID COMPOSITION. | |
ES8404348A1 (en) | Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them. | |
TW341565B (en) | Indole derivatives processes and intermediates for their preparation and pharmaceutical compositions containing them | |
ES445250A1 (en) | Certain 7-oxo-4-thio-2,6-diazabicyclo-3,2,0-hept-2-ene compounds | |
ES468173A1 (en) | 14-Amino derivatives of morphine, methods of making them and analgesic compositions containing them | |
ES428107A1 (en) | 2-1-piperazinyl-quinoxaline compounds having pharmaceutical activity | |
GB1129072A (en) | Benzofuran and indole derivatives | |
ES8307824A1 (en) | New cephem compounds and processes for preparation thereof. | |
ATE59033T1 (en) | N-CONTAINING HETEROCYCLIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THEM. | |
GB925429A (en) | Indole derivatives | |
IE782084L (en) | Quinolylguanidine derivatives | |
DK0649405T3 (en) | 22-en-25-oxa derivatives in the Vitamin D series, process for their preparation, pharmaceutical preparations containing these derivatives and use of such preparations as pharmaceuticals. | |
GB1527133A (en) | Imidazodiazepine derivatives | |
ES468170A1 (en) | 14-Amino derivatives of morphine, methods of making them and analgesic compositions containing them | |
SE7609909L (en) | NEW PENICILLINES AND PROCEDURES FOR MANUFACTURING THEM | |
RU2091378C1 (en) | 7-acyl-3-substituted carbamoylhydroxycephems, methods of their synthesis, substituted carbamoylhydroxy-3-cephems, methods of their synthesis and antibacterial composition | |
GB1468114A (en) | Triazino 4,3-a 1,4-benzodiazepin-2 1h-ones and their pharmaceuti cal compositions | |
TW362954B (en) | Stabilized composition, method for using said composition, and medium containing said | |
ES8200669A1 (en) | Heterocyclic carboxamidine compounds, their preparation and pharmaceutical compositions containing them. | |
ES2001944A6 (en) | Xanthine derivatives, processes for their production and their use as pharmaceuticals. | |
UA50722C2 (en) | Nitrobenzamides, method for their production (variants), pharmaceutical composition | |
ES8201563A1 (en) | Morpholine derivatives, process for their production, pharmaceutical preparations containing these derivatives. | |
ES8204723A1 (en) | 4-Lower hydrocarbyl-3-phenoxypyridine-1-oxides, process for their production, compositions containing them, and their use. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
704A | Declaration that licence is not available as of right for an excepted use (par. 4a/1977) | ||
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
PE20 | Patent expired after termination of 20 years |
Effective date: 19950909 |